Abstract

The question of whether the human brain is an anatomical site of persistent HIV-1 infection during suppressive antiretroviral therapy (ART) is critical, but remains unanswered. The presence of virus in the brains of HIV patients whose viral load is effectively suppressed would demonstrate not only the potential for CNS to act as an anatomical HIV reservoir, but also the urgent need to understand the factors contributing to persistent HIV behind the blood-brain barrier. Here, we investigated for the first time the presence of cells harboring HIV DNA and RNA in the brains from subjects with undetectable plasma viral load and sustained viral suppression, as identified by the National NeuroAIDS Tissue Consortium. Using new, highly sensitive in situ hybridization techniques, RNAscope and DNAscope, in combination with immunohistochemistry, we were able to detect HIV-1 in the brains of all virally suppressed cases and found that brain macrophages and microglia, but not astrocytes, were the cells harboring HIV DNA in the brain. This study demonstrated that HIV reservoirs persist in brain macrophages/microglia during suppressive ART, which cure/treatment strategies will need to focus on targeting.

Highlights

  • The combination antiretroviral therapy (ART) has converted a life-threatening human immunodeficiency virus (HIV) infection into a chronic disease

  • We set out to determine whether brain harbors HIV vDNA or viral RNA (vRNA) or both in the HIV-1-infected aviremic individuals who were on suppressive ART, as well as what type of cells harbor vDNA in those subjects

  • Using a simian immunodeficiency virus (SIV)-infected macaque model of HIV infection, Clements and colleagues showed that SIV DNA remained detectable in brain after HAART viral replication in the brain and cerebrospinal fluid (CSF)

Read more

Summary

Introduction

The combination antiretroviral therapy (ART) has converted a life-threatening human immunodeficiency virus (HIV) infection into a chronic disease. Life-long treatment is required for those with this debilitating Bincurable^ disease. Despite the widespread use of ART, HIVassociated neurocognitive disorders (HAND) remain surprisingly common (Masliah et al 2000; Sacktor et al 2002; McArthur et al 2003; Becker et al 2011; Harezlak et al 2011). Even in individuals on successful HAART with undetectable plasma viral load, HAND is still observed (Baeuerle et al 2005; Simioni et al 2010; Bingham et al 2011; Cysique and Brew 2011). The basis of HAND in virally suppressed individuals is unclear, and one possibility is that a cryptic HIV replication in the brain may occur during suppressive

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call